Twist Bioscience TWST Ratios (2017-2026)

NASDAQ TWST
$153.10 +3.04 (+2.03%)
As of: Aug 27, 2026 · 3:59 PM EDT
Reported Financials

Twist Bioscience Quarterly Ratios

Periods 35 quarters
Latest Jun 2026

Twist Bioscience reported a gross margin of 52.76% and a net margin of -29.61% for the quarter ended Jun 2026. These financial ratios cover 35 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
40.72%35.61%38.26%44.80%44.88%45.72%30.76%34.35%36.63%40.51%41.01%43.30%45.13%48.29%49.60%53.40%51.35%52.05%51.59%52.76%
EBT Margin
-107.77%-133.20%-126.37%-108.11%-88.69%-76.96%-97.18%-89.07%-69.41%-59.98%-59.95%-104.81%-41.02%-35.50%-42.19%21.43%-27.15%-29.18%-39.72%-29.35%
EBIT Margin
-104.90%-133.13%-126.34%-109.00%-99.24%-82.28%-102.42%-95.36%-74.85%-65.70%-64.92%-109.15%-42.55%-39.05%-44.79%-31.36%-30.23%-31.73%-41.42%-30.65%
EBITDA Margin
-104.90%-133.13%-126.34%-109.00%-99.24%-82.28%-102.42%-95.36%-74.85%-65.70%-64.92%-109.15%-42.55%-39.05%-44.79%-31.36%-30.23%-31.73%-41.42%-30.65%
Operating Margin
-104.90%-133.13%-126.34%-109.00%-99.24%-82.28%-102.42%-95.36%-74.85%-65.70%-64.92%-109.15%-42.55%-39.05%-44.79%-31.36%-30.23%-31.73%-41.42%-30.65%
Net Margin
-108.67%-108.44%-126.06%-107.85%-89.20%-77.10%-98.34%-90.05%-69.11%-60.15%-60.41%-105.05%-40.91%-35.62%-42.41%21.22%-27.37%-29.46%-39.76%-29.61%
FCF Margin
-113.02%-141.45%-154.40%-133.24%-30.94%-121.48%-88.64%-43.80%-34.50%-34.24%-26.59%-9.01%-20.45%-26.71%-18.46%-11.00%-24.48%-33.55%-22.98%-7.31%
Efficiency
Inventory AverageInventory Avg.
26.51M36.02M42.41M43.81M41.16M41.95M42.26M38.14M34.21M31.46M30.62M29.43M26.28M23.80M22.19M23.40M27.12M30.62M33.22M34.34M
Assets AverageAssets Avg.
713.70M744.13M903.90M1,000.65M970.52M935.67M881.95M832.13M793.37M754.61M717.83M670.48M626.22M611.45M602.10M619.61M642.73M639.97M657.15M674.33M
Invested CapitalInvested Cap.
1.55M9.08M
Asset Utilization RatioAsset Util.
0.190.200.180.180.210.230.260.280.310.350.390.440.500.540.580.580.590.610.620.64
Leverage & Solvency
Interest Coverage RatioInterest Cover
-479.65-0.00M-0.00M-0.00M-0.04M-0.03M-0.06M-0.05M-0.00M-0.00M-290.63
Debt Ratio
0.000.010.020.030.020.020.020.020.02
Times Interest Earned
-479.65-0.00M-0.00M-0.00M-0.04M-0.03M-0.06M-0.05M-0.00M-0.00M-290.63
Valuation
Enterprise Value
-477.86M-301.86M-573.86M-527.59M-504.97M-438.71M-387.66M-357.14M-336.41M-311.14M-293.34M-289.42M-276.40M-270.83M-257.15M-250.82M-232.43M-198.00M-171.70M-166.84M
Return Ratios
Return on SalesROS
-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Return on Capital EmployedROCE
-23.47%-26.48%-24.25%-23.98%-26.68%-26.23%-27.70%-29.49%-30.16%-31.84%-31.79%-39.36%-39.77%-38.48%-38.16%-26.73%-24.71%-24.04%-25.84%-26.17%
Return on Invested CapitalROIC
-0.13%-0.12%-0.13%-0.18%-0.23%
Return on AssetsROA
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%